Ovarian cancer: draft scope consultation (18th February 2009)
NICE have been asked to develop a clinical practice guideline on Ovarian Cancer for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Closing date for comments is 18th March 2009.
Consultation
Colorectal cancer: draft scope consultation (18th February 2009)
NICE have been asked to develop a clinical practice guideline on Colorectal Cancer for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Closing date for comments is 18th March 2009.
Consultation
Promoting young people's social and emotional wellbeing in secondary education: guidance consultation (18th February 2009)
NICE is developing public health intervention guidance promoting social and emotional wellbeing in secondary education. Closing date for comments is 18th March 2009.
Consultation
Hysteroscopic sterilisation by tubal cannulation and placement of intrafallopian implant (24th February 2009)
NICE has reviewed this guidance that was published in August 2004 and is reassessing the procedure. Closing date for comments is 24th February 2009.
Consultation
Corneal endothelial transplantation (24th February 2009)
The Interventional Procedures Advisory Committee has considered this procedure and NICE has now issued a consultaion document about its safety and efficacy. Closing date for comments is 24th March 2009.
Consultation
Insertion of individually magnetic resonance imaging designed unicompartmental interpositional implant in osteorthritis of the knee (24th February 2009)
The Interventional Procedures Advisory Committee has considered this procedure and NICE has now issued a consultation document about its safety and efficacy. Closing date for comments is 24th March 2009.
Consultation
Percutaneous endoscopic laser cervical discectomy (24th February 2009)
NICE has reveiwed this guidance that was published in June 2004 and has now issued a consultation document about its safety and efficacy. Closing date for comments is 24th March 2009.
Consultation
Percutaneous mitral valve leaflet repair for mitral regurgitation (24th February 2009)
The Interventional Procedures Advisory Committee reconsidered this procedure in light of comments received during the initial consultation in January 2009. Nice have now issued a second consultation document about its safety and efficacy. Closing date for comments is 24th March 2009.
Consultation
Depression in adults (update): draft guideline consultation (24th February 2009)
A clinical practice guideline on Depression in adults (update) is being developed for use in the NHS in England, Wales and Northern Ireland. Closing date for comments is 21st April 2009.
Consultation
Endovascular stent - grafts for the treatment of abdominal aortic aneuryms Technology appraisal TA167 (25th February 2009)
Endovascular stent-grafts are recommended as a possible treatment for people with abdominal aortic aneurysms if:
Amantadine, oseltamivir and zanamivir for the treatment of influenza (review of existing guidance No. 58) Technology appraisal TA168 (25th February 2009)
NICE has said that its receommendations about oseltamivir and zanamivir should not reduce efforts to give vaccination to people for whom it is recommended in national guidelines. The guidance does not cover widespread epidemics.
Guidance
Advanced breast cancer: diagnosis and treatment Clinical guideline CG81 (25th February 2009)
This guidance updates and replaces NICE technology appraisal guidance 63 (published May 2003), 54 (published December 2002) and 30 (published September 2001). The advice in the NICE guideline describes the tests, treatment, care and support that patients with advanced breast cancer should be offered. It does not specifically describe the care of patients with early breast cancer or those with rare or non-cancerous tumours of the breast.
Guidance
Early and locally advanced breast cancer: diagnosis and treatment Clinical guideline CG80 (25th February 2009)
The advice in this guideline covers some of the tests and treatments that patients with early and locally advanced breast cancer should be offered, in particular:
Rheumatoid arthritis: the management of rheumatoid arthritis in adults Clinical guideline CG79 (25th February 2009)
The advice in the NICE guideline covers the care of adults with rheumatoid arthritis. It does not specifically look at other types of arthritis such as osteoarthritis.
Guidance
Extracorporeal photopheresis for Crohn's disease Interventional procedures guidance IPG288 (25th February 2009)
Crohn's disease is a chronic inflammatory disease that affects the gastrointestinal tract. It is sometimes associated with other complications such as skin rashes and arthritis. In extracorporeal photopheresis blood is removed from the patient, then the white blood cells are separated from the whole blood, treated with ultraviolet light and re-infused into the patient.
Guidance
Intraocular lens insertion for correction of refractive error, with preservation of the natural lens Interventional procedure guidance IPG289 (25th February 2009)
Short-sightedness is the inability to see clearly at a distance. Eyesight can usually be corrected by wearing spectacles or contact lenses. Insertion of a clear plastic lens in front of the existing lens is a procedure that aims to improve vision in short-sightedness.
Guidance
Laparoscopic cystectomy Interventional procedure guidance IPG287 (25th February 2009)
This procedure is used to treat:
Needle and syringe programmes: providing people who inject drugs with injecting equipment Public health guidance PH18 (25th February 2009)
The recommendations relate to people over the age of 18 who inject illicit substances and non-prescribed anabolic steroids. The guidance complements and supports, but does not replace NICE guidance on drug and substance misuse.
Guidance
NICE have been asked to develop a clinical practice guideline on Ovarian Cancer for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Closing date for comments is 18th March 2009.
Consultation
Colorectal cancer: draft scope consultation (18th February 2009)
NICE have been asked to develop a clinical practice guideline on Colorectal Cancer for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Closing date for comments is 18th March 2009.
Consultation
Promoting young people's social and emotional wellbeing in secondary education: guidance consultation (18th February 2009)
NICE is developing public health intervention guidance promoting social and emotional wellbeing in secondary education. Closing date for comments is 18th March 2009.
Consultation
Hysteroscopic sterilisation by tubal cannulation and placement of intrafallopian implant (24th February 2009)
NICE has reviewed this guidance that was published in August 2004 and is reassessing the procedure. Closing date for comments is 24th February 2009.
Consultation
Corneal endothelial transplantation (24th February 2009)
The Interventional Procedures Advisory Committee has considered this procedure and NICE has now issued a consultaion document about its safety and efficacy. Closing date for comments is 24th March 2009.
Consultation
Insertion of individually magnetic resonance imaging designed unicompartmental interpositional implant in osteorthritis of the knee (24th February 2009)
The Interventional Procedures Advisory Committee has considered this procedure and NICE has now issued a consultation document about its safety and efficacy. Closing date for comments is 24th March 2009.
Consultation
Percutaneous endoscopic laser cervical discectomy (24th February 2009)
NICE has reveiwed this guidance that was published in June 2004 and has now issued a consultation document about its safety and efficacy. Closing date for comments is 24th March 2009.
Consultation
Percutaneous mitral valve leaflet repair for mitral regurgitation (24th February 2009)
The Interventional Procedures Advisory Committee reconsidered this procedure in light of comments received during the initial consultation in January 2009. Nice have now issued a second consultation document about its safety and efficacy. Closing date for comments is 24th March 2009.
Consultation
Depression in adults (update): draft guideline consultation (24th February 2009)
A clinical practice guideline on Depression in adults (update) is being developed for use in the NHS in England, Wales and Northern Ireland. Closing date for comments is 21st April 2009.
Consultation
Endovascular stent - grafts for the treatment of abdominal aortic aneuryms Technology appraisal TA167 (25th February 2009)
Endovascular stent-grafts are recommended as a possible treatment for people with abdominal aortic aneurysms if:
- the aneurysm is below their kidney and has not burst
- surgery is appropriate, and
- the person and their specialist have decided the risks and benefits of this and other procedures and decided that endovascular stent-grafts are appropriate
Amantadine, oseltamivir and zanamivir for the treatment of influenza (review of existing guidance No. 58) Technology appraisal TA168 (25th February 2009)
NICE has said that its receommendations about oseltamivir and zanamivir should not reduce efforts to give vaccination to people for whom it is recommended in national guidelines. The guidance does not cover widespread epidemics.
Guidance
Advanced breast cancer: diagnosis and treatment Clinical guideline CG81 (25th February 2009)
This guidance updates and replaces NICE technology appraisal guidance 63 (published May 2003), 54 (published December 2002) and 30 (published September 2001). The advice in the NICE guideline describes the tests, treatment, care and support that patients with advanced breast cancer should be offered. It does not specifically describe the care of patients with early breast cancer or those with rare or non-cancerous tumours of the breast.
Guidance
Early and locally advanced breast cancer: diagnosis and treatment Clinical guideline CG80 (25th February 2009)
The advice in this guideline covers some of the tests and treatments that patients with early and locally advanced breast cancer should be offered, in particular:
- reducing the amount of surgery under your arm
- breast reduction when breast conservation is not possible
- chemotherapy and endocrine treatments
- biological treatments
Rheumatoid arthritis: the management of rheumatoid arthritis in adults Clinical guideline CG79 (25th February 2009)
The advice in the NICE guideline covers the care of adults with rheumatoid arthritis. It does not specifically look at other types of arthritis such as osteoarthritis.
Guidance
Extracorporeal photopheresis for Crohn's disease Interventional procedures guidance IPG288 (25th February 2009)
Crohn's disease is a chronic inflammatory disease that affects the gastrointestinal tract. It is sometimes associated with other complications such as skin rashes and arthritis. In extracorporeal photopheresis blood is removed from the patient, then the white blood cells are separated from the whole blood, treated with ultraviolet light and re-infused into the patient.
Guidance
Intraocular lens insertion for correction of refractive error, with preservation of the natural lens Interventional procedure guidance IPG289 (25th February 2009)
Short-sightedness is the inability to see clearly at a distance. Eyesight can usually be corrected by wearing spectacles or contact lenses. Insertion of a clear plastic lens in front of the existing lens is a procedure that aims to improve vision in short-sightedness.
Guidance
Laparoscopic cystectomy Interventional procedure guidance IPG287 (25th February 2009)
This procedure is used to treat:
- invasive bladder carcinoma
- ongoing incontinence due to paraplegia, where catheterisation results in infection and ongoing leakage
- refractory complications in a defunctionalized bladder, where urinary diversion is already established
Needle and syringe programmes: providing people who inject drugs with injecting equipment Public health guidance PH18 (25th February 2009)
The recommendations relate to people over the age of 18 who inject illicit substances and non-prescribed anabolic steroids. The guidance complements and supports, but does not replace NICE guidance on drug and substance misuse.
Guidance
Commissioning Guides (February 2009)
NICE have published 2 new commissioning guides:
and
Consultation on the Topic Selection Process for Technology Appraisals (2nd March 2009)NICE have published 2 new commissioning guides:
and
This consultation document seeks views on some proposed changes to the way in which technology appraisal topics are selected for referral to the National Institute for Health and Clinical Excellence (NICE). Closing date for comments is 22nd May 2009.
Consultation
Consultation
Venous thromboembolism - reducing the risk: guideline consultation (2nd March 2009)
A clinical practice guideline on venous thromboembolism – reducing the risk is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations. Closing date for comments is 27th April 2009.
Consultation
A clinical practice guideline on venous thromboembolism – reducing the risk is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations. Closing date for comments is 27th April 2009.
Consultation
Depression in chronic health problems: draft guideline consultation (3rd March 2009)
A clinical practice guideline on Depression in chronic health problems is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations. Closing date for comments is 28th April 2009.
Consultation
A clinical practice guideline on Depression in chronic health problems is being developed for use in the NHS in England, Wales and Northern Ireland. Registered stakeholders for this guideline are invited to comment on the provisional recommendations. Closing date for comments is 28th April 2009.
Consultation
Breast cancer (advanced or metastatic) - lapatinib: final appraisal determination (5th March 2009)
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on Lapatinib for breast cancer (for use in women with previously treated advanced or metastatic breast cancer) and submitted it to the Institute.
The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales. The appeal period will close on 27th March 2009.
FAD
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on Lapatinib for breast cancer (for use in women with previously treated advanced or metastatic breast cancer) and submitted it to the Institute.
The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales. The appeal period will close on 27th March 2009.
FAD
Venous thromboembolism - rivaroxaban: final appraisal determination (5th March 2009)
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on rivaroxaban for the prevention of venous thromboembolism and submitted it to the Institute.
The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales. The appeal period will close on 27th March 2009.
FAD
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on rivaroxaban for the prevention of venous thromboembolism and submitted it to the Institute.
The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales. The appeal period will close on 27th March 2009.
FAD
Gastrointestinal stromal tumours - sunitinib: appraisal consultation (5th March 2009)
The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a single technology appraisal (STA) of sunitinib for the treatment of gastrointestinal stromal tumours and provide guidance on its use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted by the manufacturer and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of sunitinib for the treatment of gastrointestinal stromal tumours. Closing date for comments is 26th March 2009.
Consultation
The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a single technology appraisal (STA) of sunitinib for the treatment of gastrointestinal stromal tumours and provide guidance on its use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted by the manufacturer and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of sunitinib for the treatment of gastrointestinal stromal tumours. Closing date for comments is 26th March 2009.
Consultation
Hepatitis B - tenofovir disoproxil fumarate: appraisal consultation (5th March 2009)
The Department of Health asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a single technology appraisal (STA) of tenofovir disoproxil for the treatment of chronic hepatitis B and provide guidance on its use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted by the manufacturer and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of tenofovir disoproxil for the treatment of chronic hepatitis B. Closing date for comments is 26th March 2009.
Consultation
The Department of Health asked the National Institute for Health and Clinical Excellence (NICE or the Institute) to conduct a single technology appraisal (STA) of tenofovir disoproxil for the treatment of chronic hepatitis B and provide guidance on its use to the NHS in England and Wales. The Appraisal Committee has had its first meeting to consider both the evidence submitted by the manufacturer and the views put forward by non-manufacturer consultees and commentators, and by the clinical specialist and patient expert representatives nominated for this appraisal by non-manufacturer consultees and commentators. The Committee has developed preliminary recommendations on the use of tenofovir disoproxil for the treatment of chronic hepatitis B. Closing date for comments is 26th March 2009.
Consultation
Providing public information to prevent skin cancer: consultation on the evidence (6th March 2009)
NICE was asked by the Department of Health (DH) to develop public health intervention guidance for the NHS and local authorities on the prevention of skin cancer in the general public with specific reference to:
Consultation
NICE was asked by the Department of Health (DH) to develop public health intervention guidance for the NHS and local authorities on the prevention of skin cancer in the general public with specific reference to:
- provision of information
- physical changes to the environment
- supply of sun protection resources
Consultation
Psychosis with substance misuse: scope consultation (10th March 2009)
NICE have been asked to develop a clinical practice guideline on Psychosis with substance abuse for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Registered stakeholders for this guideline are invited to submit comments on the scope and may suggest clinical questions that could be answered in the guideline. Closing date for comments is 7th April 2009.
Consultation
NICE have been asked to develop a clinical practice guideline on Psychosis with substance abuse for use in the NHS in England, Wales and Northern Ireland. The draft scope defines what aspects of care the guideline will cover and to whom it will apply. Registered stakeholders for this guideline are invited to submit comments on the scope and may suggest clinical questions that could be answered in the guideline. Closing date for comments is 7th April 2009.
Consultation
Latest implementation tools (11th March 2009)
Tools to aid implementation of recently published guidance.
Breast cancer - early: Costing tool and Slide set
Breast cancer - advanced: Costing tool and Slide set
Rheumatoid arthritis in adults: Costing tool
Influenza (treatment) zanamivir, amantadine and oseltamivir: Costing tool and Audit Support
Abdominal aortic aneurysms - endovascular stent-grafts: Costing tool and Audit Support
Needle and syringe programmes: Slide set
Tools to aid implementation of recently published guidance.
Breast cancer - early: Costing tool and Slide set
Breast cancer - advanced: Costing tool and Slide set
Rheumatoid arthritis in adults: Costing tool
Influenza (treatment) zanamivir, amantadine and oseltamivir: Costing tool and Audit Support
Abdominal aortic aneurysms - endovascular stent-grafts: Costing tool and Audit Support
Needle and syringe programmes: Slide set
No comments:
Post a Comment